Merck to Aquire Terns Pharmaceuticals Expanding Its Hematology Pipeline with Tern-701, A Novel Candidate for Chronic Myeloid Leukemia
March 25, 2026
0
Merck & Terns Pharmaceuticals in the NEWS March 25, 2026 (GLOBE NEWSWIRE) -- Merck (MRK) - known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (